Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Harrison, Roger
Item TypeName
Concept Recombinant Fusion Proteins
Academic Article Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine.
Academic Article Antitumor Synergism and Enhanced Survival with a Tumor Vasculature-Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide.
Academic Article A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties.
Academic Article Enzyme prodrug therapy designed to target L-methioninase to the tumor vasculature.
Academic Article Purine nucleoside phosphorylase targeted by annexin v to breast cancer vasculature for enzyme prodrug therapy.
Academic Article Annexin V-Directed Enzyme Prodrug Therapy Plus Docetaxel for the Targeted Treatment of Pancreatic Cancer.
Academic Article Targeting of a novel fusion protein containing methioninase to the urokinase receptor to inhibit breast cancer cell migration and proliferation.
Academic Article Targeting a methioninase-containing fusion protein to breast cancer urokinase receptors inhibits growth and migration.
Academic Article Influence of L-methioninase targeted to the urokinase receptor on the proliferation and motility of lung and prostate cancer cells.
Academic Article Anti-CD73 and anti-OX40 immunotherapy coupled with a novel biocompatible enzyme prodrug system for the treatment of recurrent, metastatic ovarian cancer.
Academic Article Discovery of new fusion protein systems designed to enhance solubility in E. coli.
Academic Article Selective growth inhibition of cancer cells by L-methioninase-containing fusion protein targeted to the urokinase receptor.
Academic Article Annexin-directed ß-glucuronidase for the targeted treatment of solid tumors.
Search Criteria
  • Recombinant Fusion Proteins